A comparison of health care use after severe COVID-19, respiratory syncytial virus, and influenza in children

Vilde Bergstad Larsen, Ketil Størdal, Kjetil Telle, Fredrik Methi, Karin Magnusson
doi: https://doi.org/10.1101/2021.11.22.21266522

Article Information

doi 
https://doi.org/10.1101/2021.11.22.21266522
History 
  • November 24, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Vilde Bergstad Larsen1,*,
  2. Ketil Størdal2,3,
  3. Kjetil Telle1,
  4. Fredrik Methi1 and
  5. Karin Magnusson1,4
  1. 1Norwegian Institute of Public Health, Cluster for Health Services Research, Oslo, Norway
  2. 2Department of Pediatric Research, University of Oslo, Oslo, Norway
  3. 3Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway
  4. 4Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Orthopaedics, Clinical Epidemiology Unit, Lund, Sweden
  1. ↵*Corresponding author, contact information:
    Vilde Bergstad Larsen, Cluster for Health Services Research, Norwegian Institute of Public Health, Postboks 222, Skøyen, N-0213 Oslo. Visiting address: Sandakerveien 24C, Building D, 0473 Oslo. email: vildebergstad.larsen{at}fhi.no
Back to top
Posted November 24, 2021.
Download PDF

Supplementary Material

Data/Code
Email
A comparison of health care use after severe COVID-19, respiratory syncytial virus, and influenza in children
Vilde Bergstad Larsen, Ketil Størdal, Kjetil Telle, Fredrik Methi, Karin Magnusson
medRxiv 2021.11.22.21266522; doi: https://doi.org/10.1101/2021.11.22.21266522
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area